Back
Fennec Pharmaceuticals Vs. REV Group Industry Stock Comparison
Buy
71
FRX.TO
Fennec Pharmaceuticals
Last Price:
8.62
Seasonality Move:
19.08%
Buy
70
REVG
REV Group
Last Price:
33.97
Seasonality Move:
2.81%
Buy
71
Fennec Pharmaceuticals (FRX.TO)
is a Buy
Is Fennec Pharmaceuticals a Buy, Sell or Hold?
- The current Fennec Pharmaceuticals [FRX.TO] share price is $8.62. The Score for FRX.TO is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- FRX.TO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
REV Group (REVG)
is a Buy
Is REV Group a Buy, Sell or Hold?
- The current REV Group [REVG] share price is $33.99. The Score for REVG is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- REVG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FRX.TO Stock Price Chart
What is Fennec Pharmaceuticals's stock price today?
-
The Fennec Pharmaceuticals share price today is $8.62
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FRX.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.
REVG Stock Price Chart
FRX.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 64.01 | Buy |
| Chaikin Money Flow: | 200 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.22 - 8.66) | Buy |
| Bollinger Bands (100): | (6.25 - 8.27) | Buy |
REVG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.87 | Buy |
| Relative Strength Index (14 RSI): | 66.8 | Buy |
| Chaikin Money Flow: | -283349 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.49 - 31.95) | Buy |
| Bollinger Bands (100): | (26.91 - 30.43) | Buy |
FRX.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.52 | Buy |
| 20-day SMA: | 7.81 | Buy |
| 50-day SMA: | 6.84 | Buy |
| 200-day SMA: | 9.33 | Sell |
| 8-day EMA: | 8.49 | Buy |
| 20-day EMA: | 7.96 | Buy |
| 50-day EMA: | 7.38 | Buy |
| 200-day EMA: | 8.69 | Sell |
REVG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.59 | Buy |
| 20-day SMA: | 30.84 | Buy |
| 50-day SMA: | 29.17 | Buy |
| 200-day SMA: | 26.09 | Buy |
| 8-day EMA: | 31.84 | Buy |
| 20-day EMA: | 30.94 | Buy |
| 50-day EMA: | 29.7 | Buy |
| 200-day EMA: | 26.01 | Buy |
Fennec Pharmaceuticals Earnings Growth & FRX.TO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.30 per share.
REV Group Earnings Growth & REVG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.41 per share, and an increase next year of $0.69 per share.
Fennec Pharmaceuticals Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
REV Group Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||